| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular Medicine |
From the Departments of Medicine (H.S., H.E.H., D.B., L.B., B.S., R.M.), Molecular and Comparative Pathobiology (A.S., K.S., L.E.T., M.R.S., A.P.-T., C.N.M.), and Anesthesiology and Critical Care (N.F.), Johns Hopkins University School of Medicine, Baltimore, Md; and the Department of Physiology (A.C.), Northwestern University School of Medicine, Chicago, Ill. Current affiliation for K.S. and C.N.M.: Aab Cardiovascular Research Institute, University of Rochester School of Medicine & Dentistry, NY.
Correspondence to Craig Morrell, Aab Cardiovascular Research Institute, University of Rochester School of Medicine & Dentistry, 601 Elmwood Avenue, Box CVRI, Rochester, New York 14642. E-mail craig_morrell{at}urmc.rochester.edu
Rationale: Glutamate is a major signaling molecule that binds to glutamate receptors including the ionotropic glutamate receptors; kainate (KA) receptor (KAR), the N-methyl-D-aspartate receptor, and the
-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor. Each is well characterized in the central nervous system, but glutamate has important signaling roles in peripheral tissues as well, including a role in regulating platelet function.
Objective: Our previous work has demonstrated that glutamate is released by platelets in high concentrations within a developing thrombus and increases platelet activation and thrombosis. We now show that platelets express a functional KAR that drives increased agonist induced platelet activation.
Methods and Results: KAR induced increase in platelet activation is in part the result of activation of platelet cyclooxygenase in a mitogen-activated protein kinase–dependent manner. Platelets derived from KAR subunit knockout mice (GluR6–/–) are resistant to KA effects and have a prolonged time to thrombosis in vivo. Importantly, we have also identified polymorphisms in KAR subunits that are associated with phenotypic changes in platelet function in a large group of whites and blacks.
Conclusions: Our data demonstrate that glutamate regulation of platelet activation is in part cyclooxygenase-dependent and suggest that the KAR is a novel antithrombotic target.
Key Words: platelet kainate glutamate thrombosis cyclooxygenase thromboxane mitogen activated kinase p38
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |